CRISPR-Cas12 Application for the Detection of Pneumocystis jirovecii in Immunodepression Patients Through Fluorescent and Lateral Flow Colorimetric Assay
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178732 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Daniel Ulloa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Sciences, Mention in Applied Cellular and Molecular Biology, Universidad de La Frontera, Francisco Salazar Ave. 01145, Temuco 481…. Hauptthemen laut MEDLINE: Pneumocystis carinii, CRISPR-Cas Systems, Colorimetry, Pneumonia, Pneumocystis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANID - Chile, Scholarship Programa de Doctorado Nacional 2025, FONCIENCIAS - Universidad del Magdalena, Agencia Nacional de Investigación y Desarrollo (ANID)-Chile.
Abstract (Originalsprache)
Pneumonia caused by Pneumocystis jirovecii poses a serious threat, particularly to immunocompromised patients such as those with HIV/AIDS, transplant recipients, or individuals undergoing chemotherapy. Its diagnosis is challenging because current methods, such as microscopy and certain molecular tests, have limitations in sensitivity and specificity, and require specialized equipment, which delays treatment initiation. In this context, CRISPR-Cas12-based methods offer a promising alternative: they are rapid, highly specific, sensitive, and low-cost, enabling more timely and accessible detection, even in resource-limited settings. We developed a simple and rapid detection platform based on the CRISPR-Cas12 coupled with lateral flow strips. A guide RNA was designed against DHPS, β-tubulin, and mtLSU rRNA genes. The guide corresponding to β-tubulin showed high sensitivity in the detection of P. jirovecii to produce a detectable fluorescence signal within the first 20–30 min. In addition, it demonstrated high specificity for P. jirovecii when DNA from other microorganisms was used. When coupled with lateral flow strips, high sensitivity and specificity were also observed for detecting positive samples, without the need for genetic amplification. CRISPR-Cas12 successfully detected P. jirovecii infection in an initial diagnostic application, demonstrating the potential of this method for integration into public health diagnostic systems, particularly in field, due to its adaptability, speed, and ease of use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program in Sciences, Mention in Applied Cellular and Molecular Biology, Universidad de La Frontera, Francisco Salazar Ave. 01145, Temuco 4811230, Chile.
- Biochemistry Program, Universidad de La Frontera, Francisco Salazar Ave. 01145, Temuco 4811230, Chile.
- Biotechnology Program, Universidad de La Frontera, Francisco Salazar Ave. 01145, Temuco 4811230, Chile.
- Center for Genetics and Molecular Biology, Universidad del Magdalena, 29H3 Street No. 22-01, Santa Marta 470004, Colombia.
- Center of Excellence in Translational Medicine, Universidad de La Frontera, Francisco Salazar Ave. 01145, Temuco 4811230, Chile.
- Laboratory of Infectology and Clinical Immunology, Department of Preclinic Sciences, Medicine Faculty, Center of Excellence in Translational Medicine-Scientific and Technological Nucleus (CEMT-BIOREN), Universidad de La…
ORCID-Profile: Daniel Ulloa, Dayana Páez-De Ávila, Jheyson Mercado-Vides, Juan Narváez, Brian Effer, Isabel Iturrieta-González
Förderung
- ANID - Chile, Scholarship Programa de Doctorado Nacional 2025
- FONCIENCIAS - Universidad del Magdalena
- Agencia Nacional de Investigación y Desarrollo (ANID)-Chile
- FONCIENCIAS UDM010-Universidad del Magdalena
Zitieren
APA
Ulloa, D., Núñez, C., Matamala, R., San Martín, A., Páez-De Ávila, D., Mercado-Vides, J., Narváez, J., Aguirre, J., Effer, B., & Iturrieta-González, I. (2025). CRISPR-Cas12 Application for the Detection of Pneumocystis jirovecii in Immunodepression Patients Through Fluorescent and Lateral Flow Colorimetric Assay. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178732
Vancouver
Ulloa D, Núñez C, Matamala R, San Martín A, Páez-De Ávila D, Mercado-Vides J, et al. CRISPR-Cas12 Application for the Detection of Pneumocystis jirovecii in Immunodepression Patients Through Fluorescent and Lateral Flow Colorimetric Assay. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178732
BibTeX
@article{Ulloa2025,
author = {Ulloa, Daniel and Núñez, Constanza and Matamala, Romina and San Martín, Aníbal and Páez-De Ávila, Dayana and Mercado-Vides, Jheyson and Narváez, Juan and Aguirre, Juan and Effer, Brian and Iturrieta-González, Isabel},
title = {CRISPR-Cas12 Application for the Detection of Pneumocystis jirovecii in Immunodepression Patients Through Fluorescent and Lateral Flow Colorimetric Assay},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178732}
}
EUVIMED